La revue scientifique trimestrielle
Leveraging CHO cell potential in R&D and cGMP
With 25 years of experience handling hundreds of cell lines, Clean Cells is your reliable partner on both adherent and suspension models with cloning and manufacturing technologies for CHO cell lines. Our extensive portfolio of QC assays also ensures the best level of characterization for the most potent and safe CHO cells, with complementary and novel methods for monoclonal antibody characterization (ADCC).
Lire la suiteClean Cells, your partner for single cell cloning to cGMP cell banks
As a contract organization specializing in cGMP cell & virus banking and QC testing, Clean Cells knows the importance of qualitative cell line development. We thus implemented Solentim’s VIPS® PRO, a state-of-the-art single cell cloning platform to isolate potent clones and characterize the monoclonality of biotherapeutics producing cell lines, with an increased traceability as part of a regulatory compliant approach.
Lire la suiteIncreasing biologics manufacturing capacities
With 23+ years of experience handling hundreds of cell and virus models, Clean Cells has positioned itself as a leader in cell and virus banking, providing complementary characterization and storage services. Our state-of-the-art cGMP facility launched earlier this year now welcomes our biologics manufacturing capacities, providing 8 new clean rooms designed for all types of biopharma projects and equiped to meet production specifications for both adherent and suspension cells.
Lire la suiteIntegrated solution for cell banking and characterization
Clean Cells offers an integrated solution for cell bank generation in GMP and non-GMP-settings together with full characterization services and additional long-term storage options to secure valuable material.
Lire la suiteGMP biomanufacturing in a BSL-3 suite
A GMP biomanufacturing expert, Naobios has worked with numerous viruses requiring specific biocontainment procedures. Our state-of-the-art BSL-3 suite welcomes hazardous microbes used for the generation of virus-based therapeutic products.
Lire la suiteUne suite de production BPF et BSL3 – Naobios
L’équipe de Naobios a qualifié une suite de production BPF et BSL3 au sein de notre batiment polyvalent pour accueillir des projets de production BPF exigeants, impliquant des vaccins viraux, des vecteurs viraux et des virus oncolytiques.
Lire la suite